Belite Bio reported an initial statement of beneficial ownership by Hao-Yuan Chuang, a director and chief financial officer. Chuang reported direct ownership of 100,000 American depositary shares. He also reported direct ownership of 195,264 ordinary shares. Chuang reported stock options covering 144,868 ordinary shares with an exercise price of USD 0.44. He also reported stock options covering 250,000 ordinary shares with an exercise price of USD 48.46.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Belite Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-113638), on March 18, 2026, and is solely responsible for the information contained therein.